1. Home
  2. FTRK vs ELTX Comparison

FTRK vs ELTX Comparison

Compare FTRK & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRK
  • ELTX
  • Stock Information
  • Founded
  • FTRK 2012
  • ELTX 2011
  • Country
  • FTRK Singapore
  • ELTX United States
  • Employees
  • FTRK N/A
  • ELTX N/A
  • Industry
  • FTRK
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTRK
  • ELTX Health Care
  • Exchange
  • FTRK NYSE
  • ELTX Nasdaq
  • Market Cap
  • FTRK 134.1M
  • ELTX 121.7M
  • IPO Year
  • FTRK 2025
  • ELTX N/A
  • Fundamental
  • Price
  • FTRK $0.62
  • ELTX $9.89
  • Analyst Decision
  • FTRK
  • ELTX Strong Buy
  • Analyst Count
  • FTRK 0
  • ELTX 2
  • Target Price
  • FTRK N/A
  • ELTX $11.00
  • AVG Volume (30 Days)
  • FTRK 1.6M
  • ELTX 37.2K
  • Earning Date
  • FTRK 01-01-0001
  • ELTX 08-12-2025
  • Dividend Yield
  • FTRK N/A
  • ELTX N/A
  • EPS Growth
  • FTRK N/A
  • ELTX N/A
  • EPS
  • FTRK N/A
  • ELTX N/A
  • Revenue
  • FTRK $751,195.00
  • ELTX N/A
  • Revenue This Year
  • FTRK N/A
  • ELTX N/A
  • Revenue Next Year
  • FTRK N/A
  • ELTX N/A
  • P/E Ratio
  • FTRK N/A
  • ELTX N/A
  • Revenue Growth
  • FTRK N/A
  • ELTX N/A
  • 52 Week Low
  • FTRK $0.53
  • ELTX $3.70
  • 52 Week High
  • FTRK $9.69
  • ELTX $10.39
  • Technical
  • Relative Strength Index (RSI)
  • FTRK N/A
  • ELTX 75.55
  • Support Level
  • FTRK N/A
  • ELTX $9.14
  • Resistance Level
  • FTRK N/A
  • ELTX $10.39
  • Average True Range (ATR)
  • FTRK 0.00
  • ELTX 0.57
  • MACD
  • FTRK 0.00
  • ELTX 0.08
  • Stochastic Oscillator
  • FTRK 0.00
  • ELTX 79.34

About FTRK FAST TRACK GROUP

Fast Track Group is a regional entertainment-focused event management and marketing company that provides a full range of services including experiential marketing, artiste endorsement and management, movie premiere organizations, grand openings, and concerts. It also creates, develops, organizes, hosts, and manages various events and concerts.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: